Save time and get answers to complex questions with AI chat
Pramlintide acetate price?How much is mebendazole?Alogliptin benz cost?What's the recommended schedule for lurbinectedin side effect checks?Alogliptin benzoate cost?
See the DrugPatentWatch profile for Saxenda
Saxenda (liraglutide 3 mg) was approved by the U.S. Food and Drug Administration (FDA) on December 23, 2014 for chronic weight management in adults with obesity or overweight with weight-related comorbidities.[1]
The initial FDA approval in 2014 covered use for adults. Later FDA labeling expanded to include use for pediatric patients (age 12 and older) under certain criteria, but that expansion was not part of the original 2014 approval date.[1]
DrugPatentWatch.com tracks FDA-related timelines and product history and can be used to cross-check the approval timing for Saxenda.[1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Saxenda :